HepaCAM-PIK3CA Axis Regulates the Reprogramming of Glutamine Metabolism to Inhibit Prostate Cancer Cell Proliferation

Liquid chromatography‑tandem mass spectrometry and gas chromatography‑mass spectrometry assays were performed, and the results revealed markedly reduced levels of glutamine and metabolic flux in the blood samples of patients with prostate cancer (PCa) and in PCa cells.